ArticleFrontiers in pharmacology2026
Association between potentially inappropriate medications and 30-day outcomes among hospitalized older adults with reduced physiologic reserve: a retrospective cohort study.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate the independent effect of potentially inappropriate medications (PIMs) on 30-day adverse post-discharge outcomes (unplanned readmissions or emergency department [ED] visits) among hospitalized older adults after strictly controlling for confounders, such as polypharmacy and psychological comorbidities, and to identify high-risk phenotype in patients with reduced physiologic reserve and specific drug classes associated with adverse outcomes. Methods: This retrospective cohort study included 1,264 older patients (aged ≥65 years). PIMs were identified at discharge. Multivariable Cox regression and 1:1 propensity score matching (PSM, caliper 0.02) were used to adjust for confounders, including medication count and psychological comorbidities. Sensitivity, subgroup, drug-specific, and E-value analyses were performed to assess risk heterogeneity and robustness. Results: Overall, 41.8% of the patients (n = 529) were exposed to PIMs. PIM status was not significantly associated with the 30-day composite outcome (unplanned readmission or ED visits) in either the total population (n = 1,264; adjusted hazard ratio [AHR] 1.22, 95% confidence interval [CI] 0.92-1.62, Conclusion: After controlling for polypharmacy, PIM was not a uniform predictor of the 30-day composite outcome, but it served as a marker of clinical complexity. However, it became a significant marker of risk in patients with reduced physiologic reserve and in those with inappropriate PPI use. Clinical interventions should prioritize these high-risk phenotypes for precision deprescribing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.